BigDNA appoints new staff members at Roslin BioCentre
This article was originally published in Scrip
BigDNA (Scotland) has announced a number of new appointments at its company based at the Roslin BioCentre, including Dr Ewan Clark, who joins from Moredun Research Institute, and Jill Brooks, who will be responsible for the company's finance and accounts department. Big DNA, founded in 2007, designs and develops vaccines targeting diseases of unmet need and those which require improvements to existing treatments.
You may also be interested in...
Industry experts expect a continued uptick in deals valued between $2bn-$10bn this year as buyers look to add critical mass in areas like oncology, rare disease and cell and gene therapy. Divestitures to free up capital and narrow focus should continue too.
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.
As part of its response to the coronavirus outbreak, Medicines for Europe has set out a series of policy recommendations that it says could help to mitigate the risks of COVID-19.